Tanik Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.30 M
as on 21-05-2024
- Paid Up Capital ₹ 0.20 M
as on 21-05-2024
- Company Age 6 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 0.95 M
as on 21-05-2024
- Revenue 19.22%
(FY 2022)
- Profit -61.83%
(FY 2022)
- Ebitda -74.46%
(FY 2022)
- Net Worth 14.00%
(FY 2022)
- Total Assets 5.82%
(FY 2022)
About Tanik Pharmaceuticals
The Company is engaged in the Food And Beverages Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.30 M and a paid-up capital of Rs 0.20 M.
The company currently has active open charges totaling ₹0.95 M.
Ramu Kumar and Mahalakshmi Venkatesan serve as directors at the Company.
- CIN/LLPIN
U24304TN2018PTC121855
- Company No.
121855
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Apr 2018
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Tanik Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ramu Kumar  | Director | 03-Apr-2018 | Current |
| Mahalakshmi Venkatesan | Director | 03-Apr-2018 | Current |
Financial Performance and Corporate Structure Insights of Tanik Pharmaceuticals.
Tanik Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 19.22% increase. The company also saw a substantial fall in profitability, with a 61.83% decrease in profit. The company's net worth Soared by an impressive increase of 14%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Tanik Pharmaceuticals?
Unlock access to Tanik Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of India Creation Date: 27 Sep 2018 | ₹0.95 M | Open |
How Many Employees Work at Tanik Pharmaceuticals?
Unlock and access historical data on people associated with Tanik Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Tanik Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Tanik Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
